Patents by Inventor Joshua Paul

Joshua Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130066657
    Abstract: A method, system, and computer program product for providing an analysis of potential life insurance coverage, includes receiving information regarding a current life insurance policy from a user. User information, such as demographic information and a health status are received. At least part of the user information is transmitted to a plurality of life insurance carriers via an API. Quotes are received for a plurality of potential life insurance policies from the plurality of life insurance carriers. The quotes are analyzed in comparison with the information regarding the current life insurance policy, and aspects of the comparison are displayed to the user.
    Type: Application
    Filed: September 5, 2012
    Publication date: March 14, 2013
    Applicant: MY LIFE SAVINGS, LLC
    Inventor: Joshua Paul Jenkins-Robbins
  • Publication number: 20130066249
    Abstract: An arch support used by an athlete practicing his or her sport in bare feet, which consists of a metatarsal elastic compressive strap and an elastic calcaneal strap originating and terminating on the metatarsal strap using a crossing pattern on the plantar surface of the foot. Design is minimal in structure allowing the athlete to maximize contact of plantar surface of foot with the floor, or other surface, while maintaining support of foot structure.
    Type: Application
    Filed: September 12, 2011
    Publication date: March 14, 2013
    Inventor: Joshua Paul Eldridge
  • Patent number: 8385334
    Abstract: Systems and methods are provided for communication via address modulation on an communication channel. A first processing component is configured to produce a plurality of data packets. Each data packet has an associated address from a plurality of available addresses. The system further comprises a plurality of addressable entities, with each of the addressable entities being represented by a proper subset of at least two of the available addresses. A second processing component is configured to apply at least one conditioning process to the series of data packets. The first processing component is configured to select an address for each packet from the subset of available addresses representing the addressable entity associated with the packet as to communicate data between the first processing component and the second processing component.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: February 26, 2013
    Assignee: Harris Corporation
    Inventors: Joshua Paul Bruckmeyer, William Walton Boesch, Stephen Joseph Tomko, Jason Zimmermann
  • Patent number: 8383824
    Abstract: Compounds having the formula I wherein wherein R1, R2 and R3 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors with improved bioavailability. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: February 26, 2013
    Assignee: Roche Palo Alto LLC
    Inventor: Joshua Paul Gergely Taygerly
  • Patent number: 8299077
    Abstract: This application discloses 5-phenyl-1H-pyridin-2-one, 6-phenyl-2H-pyridazin-3-one, and 5-Phenyl-1H-pyrazin-2-one derivatives according to generic Formula I-III: wherein, variables Q, R, X, X?, Y1, Y2, Y2?, Y3, Y4, Y5, m, and n are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formula I-III and at least one carrier, diluent or excipient.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: October 30, 2012
    Assignee: Roche Palo Alto LLC
    Inventors: Steven Berthel, Fariborz Firooznia, Daniel Fishlock, Jun-Bae Hong, Yan Lou, Matthew Lucas, Timothy D. Owens, Keshab Sarma, Zachary Kevin Sweeney, Joshua Paul Gergely Taygerly
  • Patent number: 8180467
    Abstract: A household appliance functions according to multiple operating cycles, wherein each operating cycle comprises at least one step characterized by a parameter having a factory-set default value. A user can access a controller of the household appliance through a user interface to simultaneously set new default values for a parameter common to at least two of the multiple operating cycles.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: May 15, 2012
    Assignee: Whirlpool Corporation
    Inventors: Christopher John Woerdehoff, Joshua Paul Carroll, Andrew Charles Reck, David John Kmet
  • Publication number: 20120016692
    Abstract: A method, system, and computer program product for providing an analysis of potential life insurance coverage, includes receiving information regarding a current life insurance policy from a user. User information, such as demographic information and a health status are received. At least part of the user information is transmitted to a plurality of life insurance carriers via an API. Quotes are received for a plurality of potential life insurance policies from the plurality of life insurance carriers. The quotes are analyzed in comparison with the information regarding the current life insurance policy, and aspects of the comparison are displayed to the user.
    Type: Application
    Filed: July 15, 2010
    Publication date: January 19, 2012
    Inventor: Joshua Paul Jenkins-Robbins
  • Publication number: 20110300103
    Abstract: Method for treating an HCV infection and inhibiting HCV replication with a compound of formula I wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein
    Type: Application
    Filed: August 18, 2011
    Publication date: December 8, 2011
    Applicant: Roche Palo Alto LLC
    Inventors: Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas, Joshua Paul Gergely Taygerly
  • Publication number: 20110249191
    Abstract: Systems and methods are provided for communication via address modulation on an communication channel. A first processing component is configured to produce a plurality of data packets. Each data packet has an associated address from a plurality of available addresses. The system further comprises a plurality of addressable entities, with each of the addressable entities being represented by a proper subset of at least two of the available addresses. A second processing component is configured to apply at least one conditioning process to the series of data packets. The first processing component is configured to select an address for each packet from the subset of available addresses representing the addressable entity associated with the packet as to communicate data between the first processing component and the second processing component.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 13, 2011
    Inventors: Joshua Paul Bruckmeyer, William Walton Boesch, Stephen Joseph Tomko, Jason Zimmermann
  • Publication number: 20110249716
    Abstract: Apparatus and method are presented for measuring the transmitter and antenna system time delay (TAD) of the cadence sync at the input of a conventional 8 VSB data processing system until the emission of the segment sync of the corresponding data frame sync data segment. This includes sequentially conditioning a multi-bit input digital signal containing an initial cadence sync, inserting data patterns into the digital signal, inserting a known data pattern into the data frame at a known position of the data frame and receiving the cadence sync and the known pattern and measuring the time delay therebetween.
    Type: Application
    Filed: April 13, 2010
    Publication date: October 13, 2011
    Inventors: Joshua Paul Bruckmeyer, William Walton Boesch, Stephen Joseph Tomko
  • Patent number: 8026253
    Abstract: Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: September 27, 2011
    Assignee: Roche Palo Alto LLC
    Inventors: Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas, Joshua Paul Gergely Taygerly
  • Publication number: 20110131827
    Abstract: The Ultimate Gear Dryer is a device for drying and deodorizing the inside of athletic gear after it is damp from wear. Primarily intended for use with sport specific gloves and footwear, the device supports the gear being dried. The device combines mechanical suction of stale air from the inside of the athletic gear with the blowing of fresh air that has been passed through a filter into the athletic gear. This device helps remedy conditions that breed germs and foul scents inside the athletic gear.
    Type: Application
    Filed: December 9, 2010
    Publication date: June 9, 2011
    Inventors: Patrick John, Jean-Luc Annet, Joshua Paul Goldfarb
  • Publication number: 20110123489
    Abstract: Compounds having the formula I wherein wherein R1, R2 and R3 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors with improved bioavailability. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 26, 2011
    Applicant: Roche Palo Alto LLC
    Inventor: Joshua Paul Gergely Taygerly
  • Patent number: 7906509
    Abstract: This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-III: wherein, variables R, X, Y1, Y2, Y3, Y4, n and m are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formulae I-III and at least one carrier, diluent or excipient.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: March 15, 2011
    Assignee: Roche Palo Alto LLC
    Inventors: Joshua Kennedy-Smith, Rama K. Kondru, Bradley E. Loe, Yan Lou, Joel McIntosh, Timothy D. Owens, Michael Soth, Zachary Kevin Sweeney, Joshua Paul Gergely Taygerly
  • Publication number: 20100311760
    Abstract: Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: June 9, 2010
    Publication date: December 9, 2010
    Inventors: Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas, Joshua Paul Gergely Taygerly
  • Publication number: 20100222325
    Abstract: This application discloses 5-phenyl-1H-pyridin-2-one, 6-phenyl-2H-pyridazin-3-one, and 5-Phenyl-1H-pyrazin-2-one derivatives according to generic Formulae I-III: wherein, variables Q, R, X, X?, Y1, Y2, Y2?, Y3, Y4, Y5, m, and n are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formulae I-III and at least one carrier, diluent or excipient.
    Type: Application
    Filed: February 24, 2010
    Publication date: September 2, 2010
    Inventors: Steven Berthel, Fariborz Firooznia, Daniel Fishlock, Jun-Bae Hong, Yan Lou, Matthew Lucas, Timothy D. Owens, Keshab Sarma, Zachary Kevin Sweeney, Joshua Paul Gergely Taygerly
  • Patent number: 7771737
    Abstract: The present invention relates to compositions including medium chain peroxycarboxylic acid, methods for making these compositions, and methods for reducing the population of a microorganism. The compositions can include advantageously high levels of the medium chain peroxycarboxylic acid, can be readily made, and/or can exhibit reduced odor.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: August 10, 2010
    Assignee: Ecolab Inc.
    Inventors: Victor Fuk-Pong Man, Joshua Paul Magnuson, Steven Eugene Lentsch
  • Publication number: 20100099659
    Abstract: This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-III: wherein, variables R, X, Y1, Y2, Y3, Y4, n and m are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formulae I-III and at least one carrier, diluent or excipient.
    Type: Application
    Filed: December 11, 2009
    Publication date: April 22, 2010
    Inventors: Joshua Kennedy-Smith, Rama K. Kondru, Bradley E. Loe, Yan Lou, Joel Mclntosh, Timothy D. Owens, Michael Soth, Zachary Kevin Sweeney, Joshua Paul Gergely Taygerly
  • Patent number: 7683064
    Abstract: This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-III: wherein, variables R, X, Y1, Y2, Y3, Y4, n and m are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formulae I-III and at least one carrier, diluent or excipient.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: March 23, 2010
    Assignee: Roche Palo Alto LLC
    Inventors: Nolan James Dewdney, Joshua Kennedy-Smith, Rama K. Kondru, Bradley E. Loc, Yan Lou, Joel McIntosh, Timothy D. Owens, Michael Soth, Zachary Kevin Sweeney, Joshua Paul Gergely Taygerly
  • Patent number: D663372
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: July 10, 2012
    Inventor: Joshua Paul Wilbur